-
Expertise
- Class certification
- Damages estimation
- Fraud analysis
- Mergers and acquisitions
- Monopolization
- Pharmaceutical economics
- Reimbursement and claims data
-
Industries
- Biotechnology
- Health insurance
- Hospitals
- Medical devices
- Medicare and Medicaid
- Pharmaceuticals
- Physician groups
Spotlight
-
Bates White analysis provides support for McKesson’s acquisition of PSS World Medical
In October 2012, McKesson Corporation (McKesson), a healthcare services and information technology company, announced an agreement to purchase PSS World Medical Inc., a distributor of medical products and services, in a transaction valued at $2.1 billion.
Read more -
Economists submit amicus brief to Supreme Court in FTC v. Phoebe Putney Health System Inc.
-
Dr. Richard Manning, former pharmaceutical executive, joins Bates White's Healthcare Practice
-
-
Amgen Inc. enjoys favorable settlement with Teva Pharmaceuticals
With support from Bates White, pharmaceutical manufacturer Amgen Inc. recently settled litigation with Teva Pharmaceuticals USA Inc. concerning Teva’s challenge to the validity of Amgen’s patents for Neupogen. The client obtained a favorable outcome through an agreement that prevents Teva from introducing its infringing drug in the United States before November 2013.
Read more -
Out-of-network involuntary medical care: An analysis of emergency care provisions of the PACA
This paper, authored by Dr. T. Scott Thompson, explores new requirements found in the Patient Protection and Affordable Care Act (PACA) that impact health plans offering benefits for emergency services, and provides an economic analysis of the likely consequences of the new provisions and rules.
Read more -
Alabama Supreme Court ruling validates Eric Gaier's testimony regarding pharmaceutical pricing
The Alabama Supreme Court recently overturned three jury verdicts totaling nearly $275 million against pharmaceutical manufacturers AstraZeneca, GlaxoSmithKline, and Novartis Pharmaceuticals Corporation. The ruling cites many arguments presented by Dr. Eric Gaier, who provided deposition testimony on behalf of all three defendants and testified at trial on behalf of AstraZeneca.
Read more
Practices
Healthcare and Life Sciences
Bates White’s Healthcare and Life Sciences Practice comprises economists, academics, and industry experts who possess a deep understanding of the healthcare industry and how it is shaped by the evolving landscape of government regulation, enforcement actions, and private litigation.
Our professionals have played pivotal roles in healthcare investigations and litigation involving pricing, marketing, distribution, and reimbursement issues in cases alleging fraud, misrepresentation, breach of contract, and violation of state and federal statutes. We also have extensive experience providing economic analysis and expert testimony for clients in antitrust investigations including mergers and conduct investigations. Our defensible and rigorous approach is built on sound economic theory, extensive empirical work, and facility with critical legal issues.
As a result of our extensive healthcare litigation and consulting experience, we understand the issues that face all types of healthcare participants, including:
- Public and private medical insurance payors
- Physicians, hospitals, surgery centers, pharmacies, and other providers
- Pharmaceutical, biological, and medical device manufacturers
- The Centers for Medicare and Medicaid Services (CMS), Food and Drug Administration (FDA), Veteran’s Administration (VA), and other government entities
- Pharmacy benefit managers, group purchasing organizations, pharmaceutical wholesalers, and other healthcare intermediaries
-
Expertise
- Class certification
- Damages estimation
- Fraud analysis
- Mergers and acquisitions
- Monopolization
- Pharmaceutical economics
- Reimbursement and claims data
-
Industries
- Biotechnology
- Health insurance
- Hospitals
- Medical devices
- Medicare and Medicaid
- Pharmaceuticals
- Physician groups